Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Treatment Phase	STARTED	Doxazosin	74
Treatment Phase	STARTED	Placebo	70
Treatment Phase	COMPLETED	Doxazosin	68
Treatment Phase	COMPLETED	Placebo	69
Treatment Phase	NOT COMPLETED	Doxazosin	6
Treatment Phase	NOT COMPLETED	Placebo	1
Follow Up Phase	STARTED	Doxazosin	68
Follow Up Phase	STARTED	Placebo	69
Follow Up Phase	COMPLETED	Doxazosin	53
Follow Up Phase	COMPLETED	Placebo	47
Follow Up Phase	NOT COMPLETED	Doxazosin	15
Follow Up Phase	NOT COMPLETED	Placebo	22

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02500602/flow